Recurrent Venous Thrombosis despite Correction of Activated Protein C Resistance following Orthotopic Liver Transplantation

Douwe H. Biesma; Rob A. de Man; Karel H. Nieuwenhuis; Fred J. L. M. Haas

doi:10.1055/s-0037-1615245

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1998; 80(03): 525-526
DOI: 10.1055/s-0037-1615245

Letters to the Editor

Schattauer GmbH

Recurrent Venous Thrombosis despite Correction of Activated Protein C Resistance following Orthotopic Liver Transplantation

Douwe H. Biesma

¹From the Department of Internal Medicine

,

Rob A. de Man

²St Antonius Hospital, Nieuwegein, Department of Gastroenterology

,

Karel H. Nieuwenhuis

³Erasmus University Hospital, Rotterdam, and Department of Haematology, University Hospital, Utrecht, The Netherlands

,

Fred J. L. M. Haas

⁴From the Department of Clinical Chemistry

› Author Affiliations

Abstract

Full Text

References

References
1 Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
2 Cox D, O’Kennedy R, Thornes RD. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Human Toxicology 1989; 8: 501-6.
3 Slagboom G, Loeliger EA. Coumarin-associated hepatitis. Report of two cases. Archives of Internal Medicine 1980; 140: 1028-9.
4 De Man RA, Wilson JHP, Schalm SW, ten Cate FJW, Van Leer E. Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis. Journal of Hepatology 1990; 11: 318-21.
5 Hohler T, Schnutgen M, Helmreich-Becker L, Mayet WJ, Mayer zum Buschenfelde KH. Drug-induced hepatitis: a rare complication of oral anticoagulants. Journal of Hepatology 1994; 21: 447-9.
6 McCarthy M, Gane E, Pereira S, Tibbs CJ, Heaton N, Rela M, Hambley H, Williams R. Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut 1996; 39: 870-5.
7 Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, Deckmyn H, Colucci M, Arnout J, Vermylen J. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allo-graft recipients. Lancet 1985; i: 999-1002.
8 Cohen H, Neild GH, Patel R, Mackie IJ, Machin SJ. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients. Thrombosis Research 1988; 49: 91-101.
9 Tracy PB, Eide LL, Bowie EJW, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63.
10 Nesheim ME, Nichols WL, Cole TL, Houston JG, Schenk RB, Mann KG, Bowie EJ. Isolation and study of an acquired inhibitor of human coagulation factor V. Journal of Clinical Investigation 1986; 77: 405-15.